- Home
- Publications
- Publication Search
- Publication Details
Title
Biologics for the treatment of autoimmune renal diseases
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 12, Issue 4, Pages 217-231
Publisher
Springer Nature
Online
2016-03-07
DOI
10.1038/nrneph.2016.18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis of complement alternative pathway disorders
- (2016) Andrea Angioi et al. KIDNEY INTERNATIONAL
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Animal Models of Lupus and Lupus Nephritis
- (2015) Yong Du et al. CURRENT PHARMACEUTICAL DESIGN
- TH1and TH17cells promote crescent formation in experimental autoimmune glomerulonephritis
- (2015) Stefanie Hünemörder et al. JOURNAL OF PATHOLOGY
- Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy
- (2015) M. M. Ruseva et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The role of complement in C3 glomerulopathy
- (2015) Peter F. Zipfel et al. MOLECULAR IMMUNOLOGY
- Complement in therapy and disease
- (2015) Joost P.M. Melis et al. MOLECULAR IMMUNOLOGY
- Podocyte dysfunction in atypical haemolytic uraemic syndrome
- (2015) Marina Noris et al. Nature Reviews Nephrology
- Biologic agents in the treatment of glomerulonephritides
- (2015) See Cheng Yeo et al. NEPHROLOGY
- Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab
- (2015) Alvise Berti et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Eculizumab in the Treatment of Membranoproliferative Glomerulonephritis
- (2015) Andrew S. Bomback NEPHRON CLINICAL PRACTICE
- OP0047 A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis
- (2014) R. van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane
- (2014) S. A. Summers et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Membranous nephropathy: from models to man
- (2014) Laurence H. Beck et al. JOURNAL OF CLINICAL INVESTIGATION
- The etiology of glomerulonephritis: roles of infection and autoimmunity
- (2014) William G. Couser et al. KIDNEY INTERNATIONAL
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
- (2014) Nicola M. Tomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy
- (2014) Ozan Ozkaya et al. PEDIATRIC NEPHROLOGY
- Rituximab fails where eculizumab restores renal function in C3nef-related DDD
- (2014) Caroline Rousset-Rouvière et al. PEDIATRIC NEPHROLOGY
- Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
- (2014) Arthritis & Rheumatology
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012: Table 1
- (2013) Daniel E Furst et al. ANNALS OF THE RHEUMATIC DISEASES
- An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)
- (2013) Carol A Langford et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- CTLA-4 and autoimmunity: New insights into the dual regulator of tolerance
- (2013) Jorge Romo-Tena et al. AUTOIMMUNITY REVIEWS
- Treatment options for C3 glomerulopathy
- (2013) Carla M. Nester et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
- (2013) Fabien B. Vincent et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Regulation of TNF-α with a focus on rheumatoid arthritis
- (2013) Eva AV Moelants et al. IMMUNOLOGY AND CELL BIOLOGY
- Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting Properties
- (2013) C. Q. Schmidt et al. JOURNAL OF IMMUNOLOGY
- An Engineered Construct Combining Complement Regulatory and Surface-Recognition Domains Represents a Minimal-Size Functional Factor H
- (2013) M. Hebecker et al. JOURNAL OF IMMUNOLOGY
- Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
- (2013) D. Ricklin et al. JOURNAL OF IMMUNOLOGY
- Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features
- (2013) Gang Xin et al. JOURNAL OF NEPHROLOGY
- Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy
- (2013) Hiyori Suzuki et al. JOURNAL OF NEPHROLOGY
- Soluble CR1 Therapy Improves Complement Regulation in C3 Glomerulopathy
- (2013) Y. Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Pathogenesis of Lupus Nephritis
- (2013) M. Lech et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The HLA-DRB1*15:01-Restricted Goodpasture's T Cell Epitope Induces GN
- (2013) J. D. Ooi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
- (2013) H. Xiao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C3 glomerulopathy: consensus report
- (2013) Matthew C. Pickering et al. KIDNEY INTERNATIONAL
- Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial
- (2013) Andrew Howman et al. LANCET
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
- (2013) C.M. Legendre et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab and recurrent C3 glomerulonephritis
- (2013) Sevgi Gurkan et al. PEDIATRIC NEPHROLOGY
- Evolution of immunoglobulin deposition in C3-dominant membranoproliferative glomerulopathy
- (2013) Eric Kerns et al. PEDIATRIC NEPHROLOGY
- Successful management of Churg-Strauss syndrome using omalizumab as adjuvant immunomodulatory therapy: First documented pediatric case
- (2013) E. Iglesias et al. PEDIATRIC PULMONOLOGY
- Complement Regulation in Renal Disease Models
- (2013) Abhijit Naik et al. SEMINARS IN NEPHROLOGY
- A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
- (2013) John Rathbone et al. BMJ Open
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- Recurrent Dense Deposit Disease After Renal Transplantation: An Emerging Role for Complementary Therapies
- (2012) J. A. McCaughan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- The landscape after LUNAR: Rituximab's crater-filled path
- (2012) Liz Lightstone ARTHRITIS AND RHEUMATISM
- Association of Epitope Spreading of Antiglomerular Basement Membrane Antibodies and Kidney Injury
- (2012) J.-l. Chen et al. Clinical Journal of the American Society of Nephrology
- Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
- (2012) A. S. Bomback et al. Clinical Journal of the American Society of Nephrology
- Role of TWEAK in lupus nephritis: A bench-to-bedside review
- (2012) Jennifer S. Michaelson et al. JOURNAL OF AUTOIMMUNITY
- Basic and Translational Concepts of Immune-Mediated Glomerular Diseases
- (2012) W. G. Couser JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pathology after Eculizumab in Dense Deposit Disease and C3 GN
- (2012) L. C. Herlitz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up
- (2012) Sanjeev Sethi et al. KIDNEY INTERNATIONAL
- Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
- (2012) Aude Servais et al. KIDNEY INTERNATIONAL
- B-cell depletion in the treatment of lupus nephritis
- (2012) Jon W. Gregersen et al. Nature Reviews Nephrology
- Extraglomerular C3 deposition and metabolic impacts in patients with IgA nephropathy
- (2012) I. Ohsawa et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Targeting B-cells in lupus nephritis: should cautious optimism remain?
- (2012) Brad H. Rovin NEPHROLOGY DIALYSIS TRANSPLANTATION
- Genetically Distinct Subsets within ANCA-Associated Vasculitis
- (2012) Paul A. Lyons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab for the Treatment of Dense-Deposit Disease
- (2012) Marina Vivarelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab in a Patient with Dense-Deposit Disease
- (2012) Erica Daina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Membranoproliferative Glomerulonephritis — A New Look at an Old Entity
- (2012) Sanjeev Sethi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab and Refractory Membranoproliferative Glomerulonephritis
- (2012) Seetha Radhakrishnan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imbalance of regulatory T cells to Th17 cells in IgA nephropathy
- (2012) Fu-Jun Lin et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- Chapter 14: Anti-glomerular basement membrane antibody glomerulonephritis
- (2012) Kidney International Supplements
- Chapter 13: Pauci-immune focal and segmental necrotizing glomerulonephritis
- (2012) Kidney International Supplements
- Therapeutic blockade of TNF in patients with SLE—Promising or crazy?
- (2011) Martin Aringer et al. AUTOIMMUNITY REVIEWS
- Churg–Strauss syndrome
- (2011) Augusto Vaglio et al. CURRENT OPINION IN RHEUMATOLOGY
- The Emergence of Th17 Cells as Effectors of Renal Injury
- (2011) A. R. Kitching et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
- (2011) L. H. Beck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)
- (2011) JT Merrill et al. LUPUS
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary IgA Nephropathy: New Insights Into Pathogenesis
- (2011) Jonathan Barratt et al. SEMINARS IN NEPHROLOGY
- Membranoproliferative Glomerulonephritis: Pathogenetic Heterogeneity and Proposal for a New Classification
- (2011) Sanjeev Sethi et al. SEMINARS IN NEPHROLOGY
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity
- (2010) B. A. WIEL et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
- (2010) F. C. Fervenza et al. Clinical Journal of the American Society of Nephrology
- B-lymphocyte activating factor levels are increased in patients with Wegener’s granulomatosis and inversely correlated with ANCA titer
- (2010) Lucius Bader et al. CLINICAL RHEUMATOLOGY
- Sustained response to mepolizumab in refractory Churg-Strauss syndrome
- (2010) Jean-Emmanuel Kahn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
- (2010) Sophia Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Evolution of anti- CD20 monoclonal antibody therapeutics in oncology
- (2010) Ezogelin Oflazoglu et al. mAbs
- C3 glomerulopathy: a new classification
- (2010) Fadi Fakhouri et al. Nature Reviews Nephrology
- Prospective study of TNF blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement
- (2010) S. Laurino et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Addition of Infliximab to Standard Therapy for ANCA-Associated Vasculitis
- (2010) Matthew D. Morgan et al. NEPHRON CLINICAL PRACTICE
- Effect of Single-Dose Rituximab on Primary Glomerular Diseases
- (2010) Hidekazu Sugiura et al. NEPHRON CLINICAL PRACTICE
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM Nephritis
- (2010) Vadim Pedchenko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
- (2009) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent Patients
- (2009) A. Segarra et al. Clinical Journal of the American Society of Nephrology
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IL-23, not IL-12, Directs Autoimmunity to the Goodpasture Antigen
- (2009) J. D. Ooi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
- (2008) Alicja Kalinowska et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Omalizumab and Churg-Strauss syndrome
- (2008) Pedro Giavina-Bianchi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
- (2008) A. G. Gharavi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
- (2008) A. Schreiber et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
- (2008) Renate Kain et al. NATURE MEDICINE
- Apparent response to anti-IgE therapy in two patients with refractory "forme fruste" of Churg-Strauss syndrome
- (2008) S Pabst et al. THORAX
- Microbial IgA Protease Removes IgA Immune Complexes from Mouse Glomeruli In Vivo: Potential Therapy for IgA Nephropathy
- (2007) Michael E. Lamm et al. AMERICAN JOURNAL OF PATHOLOGY
- Rituximab treatment of idiopathic membranous nephropathy
- (2007) F.C. Fervenza et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search